annual CAPEX:
$203.00K-$1.41M(-87.44%)Summary
- As of today (August 20, 2025), STOK annual capital expenditures is $203.00 thousand, with the most recent change of -$1.41 million (-87.44%) on December 31, 2024.
- During the last 3 years, STOK annual CAPEX has fallen by -$997.00 thousand (-83.08%).
- STOK annual CAPEX is now -94.88% below its all-time high of $3.96 million, reached on December 31, 2022.
Performance
STOK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$154.00K+$2000.00(+1.32%)Summary
- As of today (August 20, 2025), STOK quarterly capital expenditures is $154.00 thousand, with the most recent change of +$2000.00 (+1.32%) on June 30, 2025.
- Over the past year, STOK quarterly CAPEX has increased by +$108.00 thousand (+234.78%).
- STOK quarterly CAPEX is now -92.41% below its all-time high of $2.03 million, reached on September 30, 2022.
Performance
STOK quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$451.00K+$108.00K(+31.49%)Summary
- As of today (August 20, 2025), STOK TTM capital expenditures is $451.00 thousand, with the most recent change of +$108.00 thousand (+31.49%) on June 30, 2025.
- Over the past year, STOK TTM CAPEX has dropped by -$219.00 thousand (-32.69%).
- STOK TTM CAPEX is now -88.62% below its all-time high of $3.96 million, reached on December 31, 2022.
Performance
STOK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
STOK CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.4% | +234.8% | -32.7% |
| 3 y3 years | -83.1% | -77.4% | -77.4% |
| 5 y5 years | -87.6% | +90.1% | -75.5% |
STOK CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.9% | at low | -92.4% | +1183.3% | -88.6% | +122.2% |
| 5 y | 5-year | -94.9% | at low | -92.4% | +1183.3% | -88.6% | +122.2% |
| alltime | all time | -94.9% | +79.7% | -92.4% | +1183.3% | -88.6% | +1634.6% |
STOK CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $154.00K(+1.3%) | $451.00K(+31.5%) |
| Mar 2025 | - | $152.00K(+261.9%) | $343.00K(+69.0%) |
| Dec 2024 | $203.00K(-87.4%) | $42.00K(-59.2%) | $203.00K(-47.9%) |
| Sep 2024 | - | $103.00K(+123.9%) | $390.00K(-41.8%) |
| Jun 2024 | - | $46.00K(+283.3%) | $670.00K(-54.2%) |
| Mar 2024 | - | $12.00K(-94.8%) | $1.46M(-9.5%) |
| Dec 2023 | $1.62M(-59.2%) | $229.00K(-40.2%) | $1.62M(-10.0%) |
| Sep 2023 | - | $383.00K(-54.4%) | $1.80M(-47.8%) |
| Jun 2023 | - | $839.00K(+408.5%) | $3.44M(+4.8%) |
| Mar 2023 | - | $165.00K(-59.7%) | $3.29M(-17.1%) |
| Dec 2022 | $3.96M(+230.2%) | $409.00K(-79.9%) | $3.96M(+5.5%) |
| Sep 2022 | - | $2.03M(+197.7%) | $3.76M(+87.9%) |
| Jun 2022 | - | $682.00K(-18.9%) | $2.00M(+8.8%) |
| Mar 2022 | - | $841.00K(+314.3%) | $1.84M(+53.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.20M(+14.3%) | $203.00K(-25.6%) | $1.20M(+10.4%) |
| Sep 2021 | - | $273.00K(-47.5%) | $1.09M(+0.4%) |
| Jun 2021 | - | $520.00K(+154.9%) | $1.08M(+68.2%) |
| Mar 2021 | - | $204.00K(+126.7%) | $644.00K(-38.7%) |
| Dec 2020 | $1.05M(-35.8%) | $90.00K(-66.5%) | $1.05M(-31.3%) |
| Sep 2020 | - | $269.00K(+232.1%) | $1.53M(-17.0%) |
| Jun 2020 | - | $81.00K(-86.7%) | $1.84M(-14.4%) |
| Mar 2020 | - | $610.00K(+7.4%) | $2.15M(+31.7%) |
| Dec 2019 | $1.64M(+74.9%) | $568.00K(-2.6%) | $1.64M(+53.2%) |
| Sep 2019 | - | $583.00K(+48.7%) | $1.07M(+120.5%) |
| Jun 2019 | - | $392.00K(+326.1%) | $484.00K(+426.1%) |
| Mar 2019 | - | $92.00K(+253.8%) | $92.00K(+253.8%) |
| Dec 2018 | $935.00K(+727.4%) | - | - |
| Mar 2018 | - | $26.00K | $26.00K |
| Dec 2017 | $113.00K | - | - |
FAQ
- What is Stoke Therapeutics, Inc. annual capital expenditures?
- What is the all time high annual CAPEX for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. annual CAPEX year-on-year change?
- What is Stoke Therapeutics, Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Stoke Therapeutics, Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. TTM CAPEX year-on-year change?
What is Stoke Therapeutics, Inc. annual capital expenditures?
The current annual CAPEX of STOK is $203.00K
What is the all time high annual CAPEX for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high annual capital expenditures is $3.96M
What is Stoke Therapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, STOK annual capital expenditures has changed by -$1.41M (-87.44%)
What is Stoke Therapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of STOK is $154.00K
What is the all time high quarterly CAPEX for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high quarterly capital expenditures is $2.03M
What is Stoke Therapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, STOK quarterly capital expenditures has changed by +$108.00K (+234.78%)
What is Stoke Therapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of STOK is $451.00K
What is the all time high TTM CAPEX for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high TTM capital expenditures is $3.96M
What is Stoke Therapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, STOK TTM capital expenditures has changed by -$219.00K (-32.69%)